US Stock MarketDetailed Quotes

HALO Halozyme Therapeutics

Watchlist
  • 62.730
  • -0.220-0.35%
Trading Mar 18 09:59 ET
7.73BMarket Cap18.29P/E (TTM)

Halozyme Therapeutics Key Stats

Halozyme Therapeutics Q4 2024 Earnings Date

Currency:USDFeb 18, 2025

Estimate
(YoY)
Actual
(YoY)
Vs Estimate
(% Chg)
Revenue
285.74M
298.01M
+12.27M
Beat Est.
+24.21%
+29.55%
+4.29%
EPS
1.01
1.06
+0.05
Beat Est.
+55.38%
+63.08%
+4.95%
Buy

Mar 18, 2025

Halozyme Therapeutics Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 6 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: USD

Actual
Estimate
DatePeriodRevenue/EstimateEarnings Call
--2025/Q2-- / 280.372M--
--2025/Q1-- / 229.294M--
Feb 18, 20252024/Q4298.008M / 285.741M--
Oct 31, 20242024/Q3290.084M / 252.167M--
Aug 6, 20242024/Q2231.353M / 204.941M--
DatePeriodRevenue/EstimateEarnings Call
--2025/Q2-- / 280.372M--
--2025/Q1-- / 229.294M--
Feb 18, 20252024/Q4298.008M / 285.741M--
Oct 31, 20242024/Q3290.084M / 252.167M--
Aug 6, 20242024/Q2231.353M / 204.941M--

Unlock Free Earnings Estimates

Halozyme Therapeutics Earnings Reports

Read more

Trending Stocks
U.S Tech Companies U.S Tech Companies

U.S leading technology companies with strong market presence, influential in their industries, and notable for robust innovation and profitability. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in U.S Tech Companies, ranked from highest to lowest based on real-time market data. U.S leading technology companies with strong market presence, influential in their industries, and notable for robust innovation and profitability. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in U.S Tech Companies, ranked from highest to lowest based on real-time market data.

Analysis

Analyst Rating

Updated: Mar 18, 2025

Buy

  • Buy

    62.50%
  • Hold

    37.50%
  • Sell

    0.00%

Price Target

No Data